Electrolyte Imbalance

• CLINICAL_TRIALS research · 2026-02-03
  Clinical Trial Update: CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS [Phase 4]

  Phase 4 clinical trial underway to evaluate reducing maintenance intravenou s saline (sodium chloride) administration in critically ill adul…

• CLINICAL_TRIALS research · 2025-07-18
  Clinical Trial Update: Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting

  A clinical trial updating the validation of a novel point-of-care dry electrolyte analysis system for acute care settings, assessing accurac…

• CLINICAL_TRIALS trial_result · 2025-05-14
  Clinical Trial Update: Buoy Electrolyte Study on Hydration Status of Active Men and Women [NA]

  The Buoy Electrolyte Study (NCT05768789) completed and posted results evaluating hydration status and electrolyte balance in active men and …

• FDA approval · 2019-08-05
  FDA Approved: PLASMA-LYTE A — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for Plasma-Lyte A, an intravenous electrolyte solution manufactured by Baxter Healthcare Corporation…

• FDA label_change · 2018-07-11
  FDA Approved: DEXTROSE AND ELECTROLYTE NO. 48 — Supplemental Application (Baxter Healthcare Company)

  FDA approved a supplemental application for Dextrose and Electrolyte No. 48, updating the product’s labeling for an IV solution containing s…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2015-05-11
  FDA Approved: RINGERS — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for RINGERS (Sodium Chloride, Calcium Chloride, Potassium Chloride) by Baxter Healthcare Corporation…

• FDA approval · 2014-09-30
  FDA Approved: RINGERS — Supplemental Application (Baxter Healthcare Corporation)

  The FDA approved a supplemental application for RINGERS electrolyte solution from Baxter Healthcare Corporation, enabling changes under the …

• FDA approval · 2013-04-26
  FDA Approved: POTASSIUM CHLORIDE IN LACTATED RINGERS AND DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved Baxter's supplemental application for Potassium Chloride in Lactated Ringers and Dextrose, an IV electrolyte solution.

• CLINICAL_TRIALS trial_result · 2012-05-03
  Clinical Trial Update: "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia [Phase 3]

  Phase 3 SALT-2 trial evaluating ascending doses of tolvaptan for hyponatremia has completed.

• FDA approval · 2011-10-19
  FDA Approved: POTASSIUM CHLORIDE IN LACTATED RINGERS AND DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for Potassium Chloride in Lactated Ringers and Dextrose, authorizing changes to its labeling and use…

• FDA approval · 2007-04-20
  FDA Approved: POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Company)

  The FDA approved a supplemental application for Baxter's potassium chloride in dextrose and sodium chloride solution.